Release Date: 13/04/17 17:48 Summary: Quarterly Activities Report, Appendix 5B Price Sensitive: No Download Document 823.62KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%